Home Healthcare NAFDAC charges pharmaceutical stakeholders on provision of quality drugs

NAFDAC charges pharmaceutical stakeholders on provision of quality drugs

NAFDAC- LagosPost.ng
Advertisement

The Director General of the National Agency for Food and Drug Administration and Control (NAFDAC), Professor Moji Adeyeye, has called on stakeholders and key players in the pharmaceutical sector to comply with the agency’s vision to provide quality medications for Nigerians.

She made the appeal during the official unveiling of the ultra-modern wholesale and distribution centre for regulated medicines put up by New Heights Pharmaceuticals.

While commending the company for keying into NAFDAC’s vision aimed at providing quality medicines for Nigerians, she said, “The vision behind this facility resonates with our traceability goal, which is to ensure that our drugs and medicines can be traced to genuine and certified manufacturers and distributors across the country, which gives caregivers and patients confidence in the type of medications they are using.

“If this is obtainable in other parts of the world, we can also do it here.”

The Registrar of the Pharmacists Council of Nigeria, Babashehu Ahmed, said the opening of the centre will hasten NAFDAC’s campaign against illegal drug distribution networks in the state.

Represented by the PCN Coordinator, Lagos Office, Ukamaka Okafor, he highlighted the successful implementation of the National Drug Distribution Guidelines in Kano State, saying the commissioning of the centre goes hand in hand with this objective.

Ogheneochuko Omaruaye, a pharmacist said NAFDAC and the PCN should expedite action on the implementation of NDDG in Lagos.

“Over 20 years ago, while working for one of the leading retail pharmacy businesses in Nigeria, we noticed the issues that most retail pharmacy stores contend with in an attempt to get quality healthcare products for them to be able to sell to their clients and give them the best quality medication, especially in the face of falsified and substandard medicine.

“In 2005, the company secured a 54-square-meter facility in Maryland to provide Nigerians with a world-class pharmaceutical healthcare space. In 2007, they visited the UK’s 4th largest pharmaceutical wholesale business, showcasing the vision for a world-class facility.

“After visiting that facility, we made a commitment that if these guys can set up such a facility in the UK, then there is no reason such a facility or something close to it should not be established in Nigeria. So that began our journey,” he said.

The Chairman, Board of Directors, Paul Enebeli, urged the Federal government to support the company to replicate the centre in the six geopolitical zones.

Advertisement

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.